Mark J. Alles's Insider Trades & SAST Disclosures

Mark J. Alles's most recent trade in Syros Pharmaceuticals Inc. was a trade of 6,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 1, 2023.

Share

Note

This is a custom search result for pattern Mark J. Alles.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Syros Pharmaceuticals Inc. Board Meeting Results	Mark J. Alles	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2023	6,000	6,000	-		-	Stock Option (right to buy)
Syros Pharmaceuticals Inc. Board Meeting Results	Mark J. Alles	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2023	4,000	4,000	-		-	Restricted Stock Units
Biomarin Pharmaceutical In...	Mark J. Alles	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 May 2023	4,190	15,095 (0%)	0%		0	Common Stock
Biomarin Pharmaceutical In...	Mark J. Alles	Director	Purchase of securities on an exchange or from another person at price $ 86.75 per share.	31 Oct 2022	3,625	10,905 (0%)	0%	86.8	314,469	Common Stock
Syros Pharmaceuticals Inc. Board Meeting Results	Mark J. Alles	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Sep 2022	12,000	12,000	-		-	Stock Option (right to buy)
Syros Pharmaceuticals Inc. Board Meeting Results	Mark J. Alles	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Sep 2022	8,000	8,000	-		-	Restricted Stock Units
Syros Pharmaceuticals Inc. Board Meeting Results	Mark J. Alles	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jun 2022	17,500	17,500	-		-	Stock Option (right to buy)
Biomarin Pharmaceutical In...	Mark J. Alles	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 May 2022	4,980	7,280 (0%)	0%		0	Common Stock
Biomarin Pharmaceutical In...	Mark J. Alles	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	2,300	2,300 (0%)	0%		0	Common Stock
Syros Pharmaceuticals Inc. Board Meeting Results	Mark J. Alles	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jun 2021	17,500	17,500	-		-	Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades